ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1009–1020 of 2020 project topics
Opioid Metabolism Pharmacogenetic Testing Enterprise Software
An enterprise-grade laboratory information system that automates CYP3A4, CYP2D6, and OPRM1 genotyping with real-time clinical decision support for opioid dosing optimization. Hospital systems and pain clinics deploy this software to reduce overdose incidents, improve patient satisfaction scores, and achieve compliance with opioid stewardship mandates.
Genetic Basis of Pain Disorders Click to view more details →
Inflammatory Pain Biomarker Discovery and Licensing Platform
A proprietary research-to-commercialization platform that identifies novel genetic variants and gene expression signatures in inflammatory pain conditions for biomarker licensing to pharmaceutical companies. This B2B service generates licensing fees and milestone payments while accelerating drug development timelines for companies targeting pain-related genetic subtypes.
Genetic Basis of Pain Disorders Click to view more details →
Polycystic Kidney Disease PKD1 and PKD2 Testing
Developing comprehensive PKD1 and PKD2 sequencing including difficult pseudogene regions for molecular diagnosis in ADPKD families.
Genetics of Urological Disorders Click to view more details →
Nephronophthisis Gene Panel Testing
Applying NPHP gene panels covering NPHP1, NPHP3, and over 20 genes for molecular diagnosis in children with nephronophthisis-related ciliopathies.
Genetics of Urological Disorders Click to view more details →
Hereditary Urolithiasis Genetic Evaluation
Testing SLC3A1, SLC7A9, AGXT, and other genes causing inherited kidney stone disorders for molecular diagnosis and prevention guidance.
Genetics of Urological Disorders Click to view more details →
Bladder Exstrophy Genetic Risk Factors
Investigating genetic contributors to bladder exstrophy-epispadias complex using family-based sequencing and candidate gene analysis.
Genetics of Urological Disorders Click to view more details →
Benign Prostatic Hyperplasia Genetic Predisposition Risk Platform
A SaaS platform that analyzes genetic variants associated with BPH susceptibility to enable personalized treatment planning and drug response prediction. This delivers recurring subscription revenue from urology clinics and enables pharmaceutical companies to identify patient populations for targeted therapeutic development.
Genetics of Urological Disorders Click to view more details →
Hypospadias Developmental Genetics Diagnostic Testing Service
A commercial laboratory service offering whole-exome sequencing and targeted gene panel analysis for hypospadias cases to identify causal variants and inheritance patterns. This generates lab fee revenue while providing clinicians with actionable genetic counseling data to improve surgical planning and family risk assessment.
Genetics of Urological Disorders Click to view more details →
Cystic Fibrosis Related Diabetes Genetic Screening Tool
An AI-powered diagnostic tool that identifies CFTR mutations and associated metabolic genes predicting diabetes risk in CF patients undergoing urological care. Revenue streams include per-test licensing fees and partnerships with CF specialty centers seeking to expand preventive screening capabilities.
Genetics of Urological Disorders Click to view more details →
Alport Syndrome Genotyping and Phenotype Prediction Software
A cloud-based platform utilizing COL4A gene sequencing and machine learning to predict renal progression severity and hearing loss risk in Alport patients. This generates SaaS licensing revenue from nephrology departments while enabling early intervention strategies that improve patient outcomes and reduce long-term complications.
Genetics of Urological Disorders Click to view more details →
Congenital Anomalies Urinary Tract Genetic Panel Service
A comprehensive multi-gene testing service targeting CAKUT-associated genes to diagnose underlying genetic causes in pediatric urological patients with congenital malformations. This captures laboratory reimbursement revenue while creating family genetic screening opportunities and expanding into prenatal diagnostic markets.
Genetics of Urological Disorders Click to view more details →
Testicular Dysgenesis Syndrome Genomic Risk Stratification Platform
A proprietary genomic analysis platform combining whole-genome sequencing with endocrine gene variant interpretation for male infertility and TDS risk prediction. This enables B2B revenue through fertility clinics, assisted reproductive technology centers, and pharmaceutical companies developing male reproductive treatments.
Genetics of Urological Disorders Click to view more details →